Stimunity is a startup company directed by Sylvain Carlioz, CEO, and located in Paris. The company exploits an exclusive license on patents from Institut Curie, INSERM and Oxford University on a biological therapeutic drug to activate the immunomodulatory STING pathway.

PI: Dr. N. Manel
Early Stage Researcher: Adriana Loverre